Conocophillips: Form 10-Q for the period ended Sep 30, 2019
Filed with the SEC on Oct 31, 2019 and accepted by EDGAR at Oct 31, 2019, 11:41 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-07-01 to 2019-09-30 | $7.76bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2019-01-01 to 2019-09-30 | $24.86bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2019-07-01 to 2019-09-30 | $2.71bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2019-01-01 to 2019-09-30 | $9.06bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2019-07-01 to 2019-09-30 | $87.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2019-01-01 to 2019-09-30 | $369.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Income tax | 3 months2019-07-01 to 2019-09-30 | $422.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2019-01-01 to 2019-09-30 | $1.72bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-07-01 to 2019-09-30 | $3.06bn | us-gaap:NetIncomeLoss |
| Net income | 9 months2019-01-01 to 2019-09-30 | $6.47bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-07-01 to 2019-09-30 | $2.74 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2019-01-01 to 2019-09-30 | $5.72 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-07-01 to 2019-09-30 | $2.76 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2019-01-01 to 2019-09-30 | $5.75 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-07-01 to 2019-09-30 | 1,113,250 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2019-01-01 to 2019-09-30 | 1,131,034 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2019-01-01 to 2019-09-30 | $8.12bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2019-01-01 to 2019-09-30 | $5.04bn | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 9 months2019-01-01 to 2019-09-30 | $1.04bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2019-01-01 to 2019-09-30 | $2.75bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-09-30 | $7.19bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-09-30 | $15.22bn | us-gaap:AssetsCurrent |
| Total assets | At period end2019-09-30 | $70.34bn | us-gaap:Assets |
| Current liabilities | At period end2019-09-30 | $5.94bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-09-30 | $35.10bn | us-gaap:Liabilities |
| Long-term debt | At period end2019-09-30 | $18.13bn | us-gaap:LongTermDebt |
| Current portion of debt | At period end2019-09-30 | $121.0m | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2019-09-30 | $35.15bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2019-09-30 | 1,097,268,667 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001193125-19-279997. Last ingested by Listed: Nov 5, 2026, 12:02 ET. Listed shows no prices and gives no investment advice.